Biostatistics for Research in Genomics and Cancer
- Institution
- UNIV OF NORTH CAROLINA CHAPEL HILL, NC
- Principal investigator
- Joseph G Ibrahim
- Funding
- $216K
- Duration
- 2004–2026
Moonbase score
Still being scored
Abstract
Project Summary This 5 year program is designed to continue to train predoctoral (PhD) students in statistical genomics with the major emphasis in cancer genomics. The goal is to train biostatisticians in the biology, etiology, and genetics of cancer, as well as to train them to conduct state-of-the-art biostatistical methodologic research relevant to the genomics of cancer as well as in related areas of genomics. The goal is to also produce biostatisticians who can collaborate with other scientific researchers and oncologists on research issues related to genomics and cancer. The typical predoctoral trainee will be a college graduate or master's level graduate with an excellent academic record appropriate for this training area. Funding is requested for the support of 5 predoctoral trainees. The Department of Biostatistics at UNC is one of the largest in the world, and has highly qualified personnel and the available facilities to provide the most comprehensive predoctoral and postdoctoral training in this research area. Several members from the Department of Genetics and the Bioinformatics and Computational Biology (BCB) program will be deeply involved in all phases of this training program and will play an integral role in this training program.
LOADING MOONBASE SCORE
Questions for UNIV OF NORTH CAROLINA CHAPEL HILL
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Univ of North Carolina Chapel HillNot yet scored
Biostatistics
Joseph G Ibrahim · $367K · 1997–2025
- NIH · Univ of North Carolina Chapel Hill65
Cortical circuits for the integration of parallel short-latency auditory pathways
Hiroyuki Kato · $469K · 2022–2027
- NIH · Univ of North Carolina Chapel Hill47
Study to establish safety, tolerability and feasibility of LM11A-31 as a neuroprotective agent in aging people living with HIV and neurocognitive impairment on antiretroviral therapy
Rick B Meeker · $638K · 2023–2029